BioSpace News Archive

Texas Children’s Hospital and Baylor College of Medicine announced today that CORBEVAX™, a protein sub-unit COVID-19 Vaccine, whose technology was created and engineered at its Center for Vaccine Development (CVD), has received Emergency Use Authorization (EUA) approval from the Drugs Controller General of India (DCGI) to launch in India with other underserved countries to follow.

180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that the Company will participate in the Biotech Showcase 2022 Virtual Conference to be held January 10-12, 2022.

Dynavax Technologies Corporation (Nasdaq: DVAX) a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Biological E reported that CORBEVAX™, their COVID-19 vaccine which contains Dynavax’s CpG 1018® adjuvant, received approval for emergency use from the Drugs Controller General of India (DCGI).

Nykode Therapeutics AS announced the first subject has been dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate in its VB-D-01 Phase 1/2 trial.

Zimmer Biomet Holdings, Inc. today announced that Chairman, President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022, at 3:00 p.m. Eastern Time.

Taysha Gene Therapies, Inc. today announced plans to provide clinical data updates, including its intent to host two virtual investor conference calls and webcasts in January 2022.

Baudax Bio, Inc. today announced that it has entered into a definitive agreement with certain institutional investors for the issuance and sale of 42,289.3 shares of convertible preferred stock and warrants to purchase up to an aggregate of 12,686,790 shares of common stock for gross proceeds of $4.2 million.

Heska Corporation announced that Kevin Wilson , Heska’s President & Chief Executive Officer, will present at the 40 th Annual J.P. Morgan Healthcare Conference on Tuesday January 11, 2022.

Hologic to Webcast Presentation at the 40th Annual J.P. Morgan Healthcare Conference.

Sosei Group Corporation, announced its Chief Financial Officer, Chris Cargill, will present at the 40th Annual J.P. Morgan Healthcare Conference, which will take place virtually, on Monday, January 10, 2022.